Analysts: Novartis AG (NOVN.VX)

NOVN.VX on Virt-X Level 1

91.55CHF
26 Nov 2014
Price Change (% chg)

-- (--)
Prev Close
CHF91.55
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,342,246
52-wk High
CHF92.20
52-wk Low
CHF67.45

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 1.22 December 27 Nov 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 6 6 6 7
(2) OUTPERFORM 7 7 9 8
(3) HOLD 12 12 12 12
(4) UNDERPERFORM 2 2 2 3
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 2.46 2.46 2.43 2.45

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 3 14,630.80 15,083.00 14,017.00 --
Year Ending Dec-14 24 58,474.00 62,401.00 53,122.00 59,283.90
Year Ending Dec-15 23 57,197.50 61,339.50 53,855.00 61,172.60
Earnings (per share)
Quarter Ending Dec-14 4 1.22 1.32 1.13 --
Quarter Ending Mar-15 1 1.30 1.30 1.30 --
Year Ending Dec-14 24 5.27 5.70 5.08 5.46
Year Ending Dec-15 23 5.77 6.13 5.15 5.97
LT Growth Rate (%) 7 7.73 9.80 4.00 4.85

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-14 14,273.20 14,704.00 430.78 3.02
Quarter Ending Jun-14 14,895.10 14,637.00 258.10 1.73
Quarter Ending Mar-14 14,279.70 14,022.00 257.72 1.80
Quarter Ending Dec-13 15,005.50 15,078.00 72.48 0.48
Quarter Ending Sep-13 14,321.20 14,338.00 16.81 0.12
Earnings (per share)
Quarter Ending Sep-14 1.31 1.37 0.06 4.52
Quarter Ending Jun-14 1.37 1.34 0.03 2.53
Quarter Ending Mar-14 1.29 1.28 0.01 0.72
Quarter Ending Dec-13 1.23 1.19 0.04 3.13
Quarter Ending Sep-13 1.27 1.26 0.01 0.72

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 14,630.80 14,630.80 14,731.20 15,118.90 --
Year Ending Dec-14 58,474.00 58,474.00 59,015.30 59,096.30 59,283.90
Year Ending Dec-15 57,197.50 57,199.70 57,557.30 57,970.90 61,172.60
Earnings (per share)
Quarter Ending Dec-14 1.22 1.22 1.17 1.19 --
Quarter Ending Mar-15 1.30 1.30 -- -- --
Year Ending Dec-14 5.27 5.27 5.21 5.27 5.46
Year Ending Dec-15 5.77 5.77 5.72 5.82 5.97

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-14 0 0 1 0
Year Ending Dec-14 0 1 6 8
Year Ending Dec-15 0 1 3 8
Earnings
Quarter Ending Dec-14 0 0 1 0
Quarter Ending Mar-15 0 0 -- --
Year Ending Dec-14 0 0 9 4
Year Ending Dec-15 0 1 11 2

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks